As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Băi wén bù rú yī jiàn“Seeing for oneself is a hundred times better than hearing from others.”Chinese Proverb from the Book of ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

"It's access on the basis of affordability." The new CalRx insulin will work as a generic version of glargine, a once-daily ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...

Civica will distribute, promote, and sell the medicine in the United States under a separate Civica label and trade dress, and in California, the product will carry the CalRx brand.

California will offer CalRx-branded biosimilar insulin glargine pens for $11 per pen beginning January 1, 2026.

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.